Inhibitors of miR-590-5p or its sponge linc02381 enhance the MAP2K3 expression and activation of p38 and AP-1 in the MAPK signaling pathway, thereby aggravating the pathogenesis of RA. The gene discussed is MAP2K3; the disease is rheumatoid arthritis.